Azitra's Series A Round

Azitra raised a round of funding on March 20, 2017. Investors include Bios Partners.

Azitra is developing a recombinant strain of skin-safe bacterium that secrete therapeutic proteins. These proteins are missing from the skin's microbiome when a person suffers from problems like eczem…

Articles about Azitra's Series A Round: